Winfried Schlee Selected Research

Tinnitus

5/2022	Cost-effectiveness of a smartphone Application for Tinnitus Treatment (the CATT trial): a study protocol of a randomised controlled trial.
12/2021	Unification of Treatments and Interventions for Tinnitus Patients (UNITI): a study protocol for a multi-center randomized clinical trial.
9/2021	Auricular Acupressure Combined with Self-Help Intervention for Treating Chronic Tinnitus: A Longitudinal Observational Study.
6/2021	Hearing Aid Fitting in Tinnitus: A Scoping Review of Methodological Aspects and Effect on Tinnitus Distress and Perception.
1/2021	Modifiable lifestyle-related risk factors for tinnitus in the general population: An overview of smoking, alcohol, body mass index and caffeine intake.
1/2021	Gender differentiates effects of acoustic stimulation in patients with tinnitus.
1/2021	Conventional versus notch filter amplification for the treatment of tinnitus in adults with mild-to-moderate hearing loss.
1/2021	Towards a unification of treatments and interventions for tinnitus patients: The EU research and innovation action UNITI.
1/2021	Emerging Topics in the Behavioral Neuroscience of Tinnitus.
1/2021	Lidocaine injections to the otic ganglion for the treatment of tinnitus-A pilot study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Winfried Schlee Research Topics

Disease

37	Tinnitus 05/2022 - 01/2007
3	Dementia (Dementias) 01/2018 - 01/2013
1	Ganglion Cysts (Ganglion) 01/2021
1	Hearing Loss (Hearing Impairment) 01/2021
1	Deafness (Deaf Mutism) 01/2020
1	Hyperacusis (Phonophobia) 01/2016
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2015
1	Cognitive Dysfunction 08/2013

Drug/Important Bio-Agent (IBA)

3	Indicators and Reagents (Reagents)IBA 01/2018 - 08/2013
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
1	Caffeine (No Doz)FDA LinkGeneric 01/2021
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2021
1	mesoglycanIBA 03/2020
1	ParvalbuminsIBA 01/2020
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2019
1	E 10 (E-10)IBA 01/2019
1	Nasal SpraysIBA 01/2017
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2017
1	Hormones (Hormone)IBA 01/2017
1	Potassium Channels (Potassium Channel)IBA 01/2016
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2016
1	PlasticsIBA 01/2013
1	Therapeutic UsesIBA 01/2012
1	salicylhydroxamic acid (SHAM)IBA 09/2010

Therapy/Procedure

11	Therapeutics 12/2021 - 02/2009
9	Transcranial Magnetic Stimulation 01/2019 - 07/2008
3	Hearing Aids (Hearing Aid) 12/2021 - 01/2021
2	Transjugular Intrahepatic Portasystemic Shunt 12/2020 - 11/2020
2	Neurofeedback 01/2007 - 01/2007
1	Exercise Therapy (Therapy, Exercise) 05/2022
1	Acupressure (Shiatsu) 09/2021
1	Injections 01/2021
1	Cochlear Implants (Cochlear Implant) 01/2020
1	Duration of Therapy 01/2019
1	Combined Modality Therapy 01/2018
1	Chronotherapy 01/2017
1	Relaxation Therapy (Relaxation Technique) 10/2016
1	Aftercare (After-Treatment) 10/2016
1	Cognitive Training 01/2015
1	Electrodes (Electrode) 01/2015
1	Activities of Daily Living (ADL) 08/2013
1	Transcranial Direct Current Stimulation 07/2008
1	Implanted Electrodes 07/2008